NUS NU SKIN ENTERPRISES INC revenue, earnings and financials
For the quarter ended June 30, 2026, NU SKIN ENTERPRISES INC reported revenue of $320M (down 17.1% from a year earlier), net income of −$250M and diluted EPS of −$5.14; over the last four quarters revenue was $1.38B and net income −$216M; for the fiscal year ended December 2025 revenue was $1.49B, down 14.3% on the year before.
NUS annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $1.49B, gross profit $1.03B, operating income $65.8M, net income $160M (margin 10.8%), EPS $3.18
- Fiscal year ended Dec 2024: revenue $1.73B, gross profit $1.18B, operating income −$152M, net income −$147M (margin -8.5%), EPS −$2.95
- Fiscal year ended Dec 2023: revenue $1.97B, gross profit $1.36B, operating income $48.3M, net income $8.60M (margin 0.4%), EPS $0.17
- Fiscal year ended Dec 2022: revenue $2.23B, gross profit $1.59B, operating income $111M, net income $105M (margin 4.7%), EPS $2.07
- Fiscal year ended Dec 2021: revenue $2.70B, gross profit $2.02B, operating income $234M, net income $147M (margin 5.5%), EPS $2.86
NUS quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $320M (down 17.1% year over year), net income −$250M, EPS −$5.14
- Quarter ended Mar 31, 2026: revenue $321M (down 12.0% year over year), net income $1.84M, EPS $0.04
- Quarter ended Dec 31, 2025 (from the annual report): revenue $370M (down 16.9% year over year), net income $14.5M, EPS $0.27
- Quarter ended Sep 30, 2025: revenue $364M (down 15.3% year over year), net income $17.1M, EPS $0.34
- Quarter ended Jun 30, 2025: revenue $386M (down 12.1% year over year), net income $21.1M, EPS $0.43
- Quarter ended Mar 31, 2025: revenue $364M (down 12.7% year over year), net income $108M, EPS $2.14
- Quarter ended Dec 31, 2024 (from the annual report): revenue $446M (down 8.8% year over year), net income −$36.1M, EPS −$0.73
- Quarter ended Sep 30, 2024: revenue $430M (down 13.8% year over year), net income $8.30M, EPS $0.17
- Quarter ended Jun 30, 2024: revenue $439M (down 12.2% year over year), net income −$118M, EPS −$2.38
- Quarter ended Mar 31, 2024: revenue $417M (down 13.3% year over year), net income −$533K, EPS −$0.01
- Quarter ended Dec 31, 2023 (from the annual report): revenue $489M (down 6.5% year over year), net income $7.28M, EPS $0.14
- Quarter ended Sep 30, 2023: revenue $499M (down 7.3% year over year), net income −$37.0M, EPS −$0.74
- Quarter ended Jun 30, 2023: revenue $500M (down 10.8% year over year), net income $26.9M, EPS $0.54
- Quarter ended Mar 31, 2023: revenue $481M (down 20.4% year over year), net income $11.4M, EPS $0.23
- Quarter ended Dec 31, 2022 (from the annual report): revenue $522M (down 22.4% year over year), net income $57.2M, EPS $1.15
- Quarter ended Sep 30, 2022: revenue $538M (down 16.1% year over year), net income −$25.4M, EPS −$0.51
- Quarter ended Jun 30, 2022: revenue $561M (down 20.4% year over year), net income $34.2M, EPS $0.67
- Quarter ended Mar 31, 2022: revenue $605M (down 10.7% year over year), net income $38.7M, EPS $0.76
- Quarter ended Dec 31, 2021 (from the annual report): revenue $673M, net income −$9.23M, EPS −$0.17
- Quarter ended Sep 30, 2021: revenue $641M, net income $49.7M, EPS $0.97
NUS cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $80.3M, share buybacks $20.0M
- Fiscal year ended Dec 2024: operating cash flow $112M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow $119M, share buybacks $13.0M
- Fiscal year ended Dec 2022: operating cash flow $108M, share buybacks $70.0M
- Fiscal year ended Dec 2021: operating cash flow $142M, share buybacks $80.4M
NUS balance sheet
- Jun 30, 2026: cash $190M, total assets $1.12B, total liabilities $579M, shareholders' equity $543M, long-term debt $194M
- Mar 31, 2026: cash $199M, total assets $1.38B, total liabilities $583M, shareholders' equity $794M, long-term debt $204M
- Dec 31, 2025: cash $239M, total assets $1.41B, total liabilities $600M, shareholders' equity $805M, long-term debt $204M
- Sep 30, 2025: cash $252M, total assets $1.42B, total liabilities $625M, shareholders' equity $800M, long-term debt $209M
- Jun 30, 2025: cash $264M, total assets $1.44B, total liabilities $656M, shareholders' equity $788M, long-term debt $214M
- Mar 31, 2025: cash $204M, total assets $1.39B, total liabilities $637M, shareholders' equity $754M, long-term debt $219M
- Dec 31, 2024: cash $187M, total assets $1.47B, total liabilities $817M, shareholders' equity $651M, long-term debt $364M
- Sep 30, 2024: cash $228M, total assets $1.58B, total liabilities $876M, shareholders' equity $707M, long-term debt $373M
What is NUS's revenue?
NU SKIN ENTERPRISES INC reported $1.38B of revenue over its last four quarters, through June 30, 2026.
Is NUS profitable?
No. NU SKIN ENTERPRISES INC lost $216M over the last four quarters.
What is NUS's EPS?
Diluted earnings per share over the last four quarters were −$4.49; −$5.14 in the latest quarter.